Literature DB >> 19273153

Can we prevent parkinson's disease?

Christine R Swanson1, Samantha L Sesso, Marina E Emborg.   

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disorder that affects 1 million people in the United States. Although the cause of PD remains unknown, a number of factors that increase the risk of developing this disease have been identified. Other factors that may prevent or slow down PD development and progression have also been found. In this review, we describe current basic, clinical and epidemiological findings on risk and neuroprotective factors and discuss how they can affect PD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19273153     DOI: 10.2741/3331

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  2 in total

Review 1.  Cell-based therapies for Parkinson's disease: past, present, and future.

Authors:  Kathleen M Fitzpatrick; James Raschke; Marina E Emborg
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

2.  The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys.

Authors:  Christine R Swanson; Valerie Joers; Viktoriya Bondarenko; Kevin Brunner; Heather A Simmons; Toni E Ziegler; Joseph W Kemnitz; Jeffrey A Johnson; Marina E Emborg
Journal:  J Neuroinflammation       Date:  2011-08-05       Impact factor: 8.322

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.